Reduction of bcr-abl transcript levels with imatinib (Gleevec) in chronic myeloid leukemia (Chronic Phase)

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)96-97
Number of pages2
JournalP and T
Volume34
Issue number2
Publication statusPublished or Issued - 1 Feb 2009
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this